Bio-Rad Laboratories has announced a new release of its KnowItAll spectroscopy software
Bio-Rad Laboratories has launched Bio-Rad Mission: Control, the first objective risk management software to help laboratories identify the best quality control (QC) rules and the right QC frequency to develop a customised quality control plan
Bio-Rad Laboratories has announced at Pittcon 2014 the release of the beta version of USP Spectral Library
Bio-Rad Laboratories has released version 9.0 of KnowItAll, which now includes an unlimited spectral range and resolution feature
Bio-Rad has announced a new feature to improve the interpretation of infrared (IR) and Raman spectra in version 8.3 of its KnowItAll software
Bio-Rad Laboratories has launched its software for its automated Experion electrophoresis system, which enables fast and high resolution results for protein, RNA, and DNA separations.
Bio-Rad Laboratories has released an addition of AnalyzeIt Polymer IR to its KnowItAll Informatics System.
Bio-Rad Laboratories has released Bio-Rad CFX96, which is a real-time PCR detection system.
Bio-Rad Laboratories has announced the pending launch later this year of two regulatory tools for the ProteOn XPR36 Protein Interaction Array System: the ProteOn Manager 2.1 Security Edition Software and the ProteOn XPR36 Installation Qualification and Operation Qualification Kit.
Bio-Rad Laboratories has released ProteOn Manager 2.0, its latest ProteOn XPR36 protein interaction array system and data management software.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
